8792 Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices 

of 1930, as amended (19 U.S.C. 1337), 

and in sections 210.45(c), 210.51(a) of 

the Commission’s Rules of Practice and 

Procedure (19 CFR 210.45(c), 210.51(a)). 

By order of the Commission. 

Issued: February 21, 2007. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. E7–3390 Filed 2–26–07; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated October 6, 2006, and 

published in the Federal Register on 

October 18, 2006, (71 FR 61510), 

Boehringer Ingelheim Chemicals Inc., 

2820 N. Normandy Drive, Petersburg, 

Virginia 23805, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedules I and II: 

Drug Schedule 

Tetrahydrocannabinols (7370) .... I 

Amphetamine (1100) .................. II 

Methylphenidate (1724) .............. II 

Methadone (9250) ...................... II 

Methadone Intermediate (9254) II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Fentanyl(9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for sale to its customers for formulation 

into finished pharmaceuticals. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Boehringer Ingelheim Chemicals Inc. to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated Boehringer Ingelheim 

Chemicals Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: February 16, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control Drug Enforcement, 

Administration. 

[FR Doc. E7–3296 Filed 2–26–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated November 21, 2006 

and published in the Federal Register 

on December 1, 2006, (71 FR 69591–

69592), Johnson Matthey, Inc., 

Pharmaceutical Materials, 2003 Nolte 

Drive, West Deptford, New Jersey 

08066–1742, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in schedule 

II: 

Drug Schedule 

Phenylacetone (8501) .................. II 

Raw Opium (9600) ....................... II 

Concentrate of Poppy Straw 

(9670) ........................................ II 

The company plans to import the 

listed controlled substances as raw 

materials for use in the manufacture of 

bulk controlled substances for 

distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Johnson Matthey Inc to import the basic 

classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated Johnson 

Matthey Inc to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and § 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: February 16, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–3299 Filed 2–26–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated November 8, 2006 

and published in the Federal Register 

on November 17, 2006, (71 FR 66974), 

Kenco VPI, Division of Kenco Group 

Inc., 350 Corporate Place, Chattanooga, 

Tennessee 37419, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Nabilone (7379), a basic 

class of controlled substance listed in 

schedule II. 

The company plans to import the 

listed controlled substance for 

distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Kenco VPI to import the basic class of 

controlled substance is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971, at this time. DEA 

has investigated Kenco VPI to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: February 16, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–3298 Filed 2–26–07; 8:45 am] 

BILLING CODE 4410–09–P 


cprice-sewell on PROD1PC62 with NOTICES